A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06453668
- Locations
- 🇸🇪
Umeå University Hospital, Umeå, Sweden
🇸🇪Skåne University Hospital Malmö, Malmö, Sweden
🇸🇪Studieenheten Akademiskt Specialistcentrum, Stockholm, Sweden
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2024-04-15
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06365437
- Locations
- 🇸🇪
Skåne University Hospital, Malmö, Sweden
🇸🇪Sahlgrenska University Hospital, Göteborg, Sweden
🇦🇹Innsbruck Medical University, Innsbruck, Austria
A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
- Conditions
- Interventions
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 96
- Registration Number
- NCT06025110
- Locations
- 🇩🇪
Institut für Diabetesforschung Münster GmbH, Münster, Germany
🇵🇱Medical University of Lodz, Łódź, Poland
🇧🇪UZ Leuven, Leuven, Belgium
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
- Conditions
- Interventions
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06019507
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Huddinge, Sweden
A Study of TCD601 in de Novo Renal Transplant Recipients
- Conditions
- Interventions
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 90
- Registration Number
- NCT05669001
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸University of Cincinnati Medical Center, Cincinnati, Ohio, United States
🇺🇸University of California San Francisco Medical Center, San Francisco, California, United States
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04803006
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸UCSF Connie Frank Transplant Center, San Francisco, California, United States
🇺🇸Cooperman Barnabas Medical Center, Livingston, New Jersey, United States
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04803058
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Dose Escalation Study in de Novo Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- ITB-Med LLC
- Target Recruit Count
- 13
- Registration Number
- NCT04311632
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Kansas University Medical Center, Kansas City, Kansas, United States